{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:47:08Z","timestamp":1780393628090,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"NRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejphar.2025.177272","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T06:33:20Z","timestamp":1736663600000},"page":"177272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Role of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition in the antiobesity effect of J2H-1702 on adipocytes and a high-fat diet-induced NASH model"],"prefix":"10.1016","volume":"989","author":[{"given":"Dahae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayeon","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaejin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Woon","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-5244","authenticated-orcid":false,"given":"Ki Sung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177272_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akkiz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177272_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/scipharm89010005","article-title":"Inhibitors of 11\u03b2-hydroxysteroid dehydrogenase type 1 as potential drugs for type 2 diabetes mellitus\u2014a systematic review of clinical and in vivo preclinical studies","volume":"89","author":"Almeida","year":"2021","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejphar.2025.177272_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1210\/jc.2002-021194","article-title":"Effects of the 11\u03b2-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes","volume":"88","author":"Andrews","year":"2003","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2025.177272_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.814030","article-title":"Mass cytometry study on hepatic fibrosis and its drug-induced recovery using mouse peripheral blood mononuclear cells","volume":"13","author":"Bae","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177272_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/toxsci\/kfg195","article-title":"Effects of inorganic HgCl2 on adipogenesis","volume":"75","author":"Barnes","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2025.177272_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2016.08.016","article-title":"PPP2R5B, a regulatory subunit of PP2A, contributes to adipocyte insulin resistance","volume":"437","author":"Beg","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.177272_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2004.10.018","article-title":"The role of MAPKs in adipocyte differentiation and obesity","volume":"87","author":"Bost","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.ejphar.2025.177272_bib8","article-title":"Hepatic stellate cells role in the course of metabolic disorders development - a molecular overview","volume":"170","author":"Bourebaba","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177272_bib9","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3748\/wjg.v16.i42.5286","article-title":"Histopathology of nonalcoholic fatty liver disease","volume":"16","author":"Brunt","year":"2010","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.ejphar.2025.177272_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1478-3231.2011.02685.x","article-title":"Overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease","volume":"32","author":"Candia","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2025.177272_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112134","article-title":"Progress in 11\u03b2-HSD1 inhibitors for the treatment of metabolic diseases: a comprehensive guide to their chemical structure diversity in drug development","volume":"191","author":"Chuanxin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177272_bib12","doi-asserted-by":"crossref","first-page":"32111","DOI":"10.1074\/jbc.273.48.32111","article-title":"Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis","volume":"273","author":"Engelman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177272_bib13","series-title":"Kidney Damage in Obese Subjects: Oxidative Stress and Inflammation, Obesity","first-page":"135","author":"Escasany","year":"2018"},{"key":"10.1016\/j.ejphar.2025.177272_bib14","article-title":"Pathologic proteolytic processing of N-cadherin as a marker of human fibrotic disease","volume":"11","author":"Ferrell","year":"2022","journal-title":"Cells-Basel"},{"key":"10.1016\/j.ejphar.2025.177272_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/10715760802158448","article-title":"Chronic insulin treatment causes insulin resistance in 3T3-L1 adipocytes through oxidative stress","volume":"42","author":"Ge","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2025.177272_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1216783","article-title":"Differential role of adipose tissues in obesity and related metabolic and vascular complications","volume":"2016","author":"G\u00f3mez-Hern\u00e1ndez","year":"2016","journal-title":"International journal of endocrinology"},{"key":"10.1016\/j.ejphar.2025.177272_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/bbrc.2000.3966","article-title":"PPAR\u03b1 agonists reduce 11\u03b2-hydroxysteroid dehydrogenase type 1 in the liver","volume":"279","author":"Hermanowski-Vosatka","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.177272_bib44","doi-asserted-by":"crossref","first-page":"104887","DOI":"10.1016\/j.ebiom.2023.104887","article-title":"P. mirabilis-derived pore-forming haemolysin, HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration","volume":"98","author":"Huh","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2025.177272_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177272_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92902","article-title":"CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"2","author":"Itoh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2025.177272_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.17726","article-title":"First in human randomised trial of J2H\u20101702: a novel 11\u03b2\u2010hydroxysteroid dehydrogenase type 1 inhibitor for non\u2010alcoholic steatohepatitis treatment","volume":"58","author":"Kim","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2025.177272_bib21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/hep.23797","article-title":"High\u2010fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis","volume":"52","author":"Kohli","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2025.177272_bib22","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1152\/ajpendo.00029.2013","article-title":"Regulation of 11\u03b2-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-\u03baB and HIF-1\u03b1","volume":"304","author":"Lee","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2025.177272_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2013.05.029","article-title":"Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2025.177272_bib24","article-title":"Glucocorticoid receptor and adipocyte biology","volume":"vol. 5","author":"Lee","year":"2018"},{"key":"10.1016\/j.ejphar.2025.177272_bib43","article-title":"Glucose-lowering effect of Reducose\u00ae enriched with 1-deoxynojirimycin and l-leucine: Studies on insulin secretion in INS-1 cells and reduction of blood glucose in diabetic rats","volume":"10","author":"Lee","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2025.177272_bib45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jgr.2023.02.001","article-title":"Protopanaxadiol ameliorates palmitate-induced lipotoxicity and pancreatic \u03b2-cell dysfunction in INS-1 cells","volume":"47","author":"Lee","year":"2023","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.ejphar.2025.177272_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177272_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.metabol.2011.11.008","article-title":"Antisense reduction of 11\u03b2-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL\/6J mice on a Western-type diet","volume":"61","author":"Li","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2025.177272_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/CS20180873","article-title":"Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis","volume":"133","author":"Li","year":"2019","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2025.177272_bib28","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177272_bib29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2015.10.042","article-title":"A potent and selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models","volume":"768","author":"Oh","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177272_bib30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bcp.2011.01.020","article-title":"Anti-diabetic and anti-adipogenic effects of a novel selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1, 1-dioxo-2H-1, 2-benzothiazine-2-yl-1-phenylethanone (KR-66344)","volume":"81","author":"Park","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177272_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00260-16","article-title":"Glucocorticoid receptor accelerates, but is dispensable for, adipogenesis","volume":"37","author":"Park","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177272_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep37160","article-title":"11\u03b2-Hydroxysteroid Dehydrogenase Type 1 (11\u03b2-HSD1) mediates insulin resistance through JNK activation in adipocytes","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177272_bib33","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/ijms19092778","article-title":"Modulation of insulin resistance and the adipocyte-skeletal muscle cell cross-talk by LCn-3PUFA","volume":"19","author":"Pinel","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177272_bib34","doi-asserted-by":"crossref","first-page":"46226","DOI":"10.1074\/jbc.M207776200","article-title":"Activation of MEK\/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and C\/EBP\u03b1 gene expression during the differentiation of 3T3-L1 preadipocytes","volume":"277","author":"Prusty","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177272_bib35","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1021\/acs.jmedchem.6b01122","volume":"59","author":"Ryu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177272_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/427640","article-title":"Chronic inhibition of 11\u03b2-hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome","volume":"2013","author":"Schnackenberg","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2025.177272_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/1751-2980.12967","article-title":"Efficacy and safety of drugs for nonalcoholic steatohepatitis","volume":"22","author":"Shen","year":"2021","journal-title":"Journal of Digestive Diseases"},{"key":"10.1016\/j.ejphar.2025.177272_bib38","first-page":"37","article-title":"The role and regulation of 11\u03b2-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome","volume":"15","author":"Stimson","year":"2013","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.ejphar.2025.177272_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1043-2760(02)00581-7","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"13","author":"Szidonya","year":"2002","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2025.177272_bib40","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-\u03b1 production","volume":"287","author":"Tosello-Trampont","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177272_bib41","first-page":"3191","article-title":"11\u03b2-hydroxysteroid dehydrogenase-1 is associated with the activation of hepatic stellate cells in the development of hepatic fibrosis","volume":"22","author":"Xiao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2025.177272_bib42","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:04:12Z","timestamp":1740373452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"alternative-id":["S0014299925000251"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177272","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibition in the antiobesity effect of J2H-1702 on adipocytes and a high-fat diet-induced NASH model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177272"}}